FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:2554-2556 December 9, 2004 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Eschenbach, D. A. Related Article by Sobel, J. D. PubMed Citation

To the Editor: The results of the study of maintenance fluconazole therapy for recurrent vulvovaginal candidiasis by Sobel et al. (Aug. 26 issue)¹ are misleading. A better assessment of the effect of weekly maintenance fluconazole therapy would be obtained by comparing the proportions of women who were free of disease at a given time after the most recent dose of fluconazole. This study shows that women who receive weekly therapy with fluconazole for six months have a 57 percent chance of a recurrence within six months after the last dose of fluconazole, whereas women who receive one dose of fluconazole . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.